Resources

Information on PSCI and resource materials on pharmaceutical supply chain sustainability.

The resources are particularly targeted at companies working in the supply chain – our suppliers – who are warmly encouraged to make free use of all the materials here.

We will continue to build this section over time. If you have any suggestions on how we can improve it please contact us.

Key Resources

Search for a resource by typing a word or phrase into the search box.

Filter by topic, target audience and category by clicking each of the filter buttons and choosing a filter from the list that appears.

Clear Filters
1 2 3 4 5 6 all

Freedom of Association, Overview

Document
9 Jul 2015

An introduction to the topic of Freedom of Association.

Freedom of Association, Additional Resources

Document
9 Jul 2015

Organisations and reference material relating to Freedom of Association.

ETI Freedom of Association and Collective Bargaining

Link
9 Jul 2015

This briefing document seeks to explain clearly what freedom of association and the right to collective bargaining mean.

Fair Treatment, Additional Resources

Document
9 Jul 2015

Links to organisations involved in the fair treatment of employees, along with reference material.

Fair Treatment, Overview

Document
9 Jul 2015

An introduction to the issue of harassment in the workplace.

Child Labor & Young Workers, Additional Resources

Document
9 Jul 2015

Links to additional resources including organisations involved in ending child labor and reference material.

Child Labor & Young Workers, Sample Action Plan

Document
9 Jul 2015

An example of how to deal with child labor.

Child Labor & Young Workers, Overview

Document
9 Jul 2015

An introduction to child labor & young workers.

Tackling Child Labour - Danish Ethical Initiative

Link
9 Jul 2015

Information on tackling child labour in Global Supply Chains from the Danish Ethical Trading Initiative.

Risk identification model Flubendazole

Document
8 Jul 2015

Risk identification model Flubendazole

RBEAP solvent template

Document
8 Jul 2015

RBEAP solvent template

RBEAP introduction

Document
8 Jul 2015

Risk Based Exposure Assessment Process

RBEAP instructions for use

Document
8 Jul 2015

Guidelines and Instructions for Using Risk Based Exposure Assessment Process (RBEAP) Form

Objectives: To provide a tool and system that helps organize and document the decision for establishing an IH sampling strategy to assess risk.

RBEAP API template

Document
8 Jul 2015

Risk Based Exposure Assessment Process (RBEAP)

UNICEF Resource on Child Labor Issues

Link
8 Jul 2015

UNICEF Resource on Child Labor Issues

Labor - Overview and Management Systems

Document
8 Jul 2015

Companies should use a management system to facilitate continual improvement and compliance with labor standards.

General Resources

Document
8 Jul 2015

Resources including Organisations and Reference Material.

ESP - Practical Handbook on Business and Human Rights

Link
8 Jul 2015

The practical handbook on Business and Human Rights.

Sustainable Development Policy Example

Link
8 Jul 2015

Bayer's sustainable development policy.

UN Global Compact Supply Chain Guidance

Link
8 Jul 2015

Multiple resources concerning the supply chain from UN Global Compact.

Worker Protection Overview

Document
8 Jul 2015

Once the hazards in the workplace have been identified and categorized by type, location and degree, appropriate preventive and protective steps should be taken to deal with the hazards. Although Worker Protection is commonly equated to Personal Protective Equipment (PPE), PPE should actually be the last line of defence in the effort to protect workers.

Written Hearing Conservation Program

Document
8 Jul 2015

This document has been developed as a program guideline for companies who are
required to have a written Hearing Conservation Program.

Handling Cytostatic Drugs

Link
8 Jul 2015

Handling cytostatic drugs requires a number of organizational and technical systems in order to guarantee the best possible protection for personnel. This booklet focuses on various ways of protecting personnel from potential hazards through the careful handling of cytostatic drugs, and for this reason, product protection is only briefly discussed.

Process Safety

Document
8 Jul 2015

Process Safety Management (PSM) is recognized as Good Manufacturing Practice. In many countries PSM is covered by specific regulations. The general intent of PSM is to provide safe processes that define and manage risk based on common management practice designed to identify and mitigate hazards.

Dust Explosion Data - How to Identify and Communicate the Hazard

Document
8 Jul 2015

PowerPoint on dust hazards, their identification and communication.

Biological Hazards

Document
8 Jul 2015

Biological hazards arise from exposure to hormones, viruses, fungi, bacteria or any other living organisms that can cause harm, illness, or damage to the human body.

Chemical Hazards

Document
8 Jul 2015

Each chemical is different from the next one and therefore each chemical has different characteristics that help define the hazards that may be present.

Physical Hazards

Document
8 Jul 2015

Physical hazards are those hazards arising from work-related tasks as well as from the physical environment in which work is being performed.

Non-Ionizing Radiation Safety Program

Document
8 Jul 2015

The purpose of the non-ionizing radiation safety program is to ensure the safe use of Non-Ionizing Radiation (NIR) sources and to meet the expectations of the Standards.

Safe Handling of New Molecular Entities

Document
8 Jul 2015

Pharmaceutical Industry’s Approach to Safe Handling of New Molecular Entities.

Confined Space Fatality - Investigation Report

Document
8 Jul 2015

Example of a document produced after a fatality.

Handling Highly Potent Active Pharmaceutical Ingredients - Safebridge

Document
8 Jul 2015

Equipment containment performance: Potent and highly potent active pharmaceutical ingredients have the potential to cause serious health effects in workers at very low airborne concentrations. The use of containment equipment as part of a systematic approach to potent compound safety is advised to control worker exposure. However the containment performance of equipment can not be assumed, evaluation of containment performance, using a standardised approach, should be adopted.

Overview and Industrial Hygiene Management Systems

Document
8 Jul 2015

An overview of Industrial hygiene and hazard assessment in the workplace.

External Manufacturing EHS Best Practices

Document
8 Jul 2015

This paper provides an overview of some of the current best practices which have been developed for external manufacturing for both the Chemical and Pharmaceutical industries.

Plastic Chemical and Condition Compatibility Chart

Document
8 Jul 2015

This chart is provided as a general guide for plastic chemical and condition compatibility.

OSHA - Small Business Handbook

Link
8 Jul 2015

This handbook is provided to owners, proprietors and managers of small businesses by the Occupational Safety and Health Administration (OSHA), an agency of the U.S. Department of Labor. It should help small business employers meet the legal requirements imposed by the Occupational Safety and Health Act of 1970 (the Act), and achieve an in-compliance status before an OSHA inspection.

Find an EHS Consultant

Link
8 Jul 2015

The Premier Directory of Industrial Hygiene and Occupational and Environmental Health and Safety Consulting Professionals.

Transparency International on Adequate Procedures

Link
7 Jul 2015

The UK Bribery Act, which was passed in 2010, introduces an offence of corporate failure to prevent bribery. The defence for a company against this liability is to prove that it had adequate procedures in place to prevent bribery. This Guidance from Transparency International UK (TI-UK) is designed to assist companies to comply with the Bribery Act by providing clear, practical advice on good practice anti-bribery systems that in TI-UK's opinion constitute 'adequate procedures' for compliance with the Bribery Act.

Animal Studies

Link
7 Jul 2015

The link provides Bayer’s principles for animal welfare and animal testing and their responsibility for the safety of our products and thus for people, animals and the environment, and the well-being of laboratory animals.

Business Code of Conduct

Document
7 Jul 2015

The Novo Nordisk Way, an example of the Business Code of Conduct.

Best Management Practices for Leak and Spill Control

Document
7 Jul 2015

Keeping a facility clean helps improve productivity and employee morale. In addition, it
presents a positive image to customers, stakeholders and the community. A clean facility can also help ensure greater compliance with environmental, health and safety regulations. Leaks and spills can happen anywhere – from the front office to the shipping dock; and beyond. These spills create waste and can lead to costly environmental fines - especially if the spill leaves the facility. Leaks and spills can also contribute to worker injuries, causing piles of medical bills, workman’s compensation claims and lost work time.

Water Position

Document
7 Jul 2015

An example is Bayer's “Science For A Better Life” where they promise innovative solutions to global economic, ecological and social challenges. The availability of fresh water is a growing concern around the world. Water is not only essential for life on earth but also for many industry sectors of the global economy and for us as a pharmaceutical and chemical company with energy and water intensive operations.

Climate Change Position

Document
7 Jul 2015

An example is Novo Nordisk's climate strategy, which is developed in accordance with the Greenhouse Gas Protocol. It includes all scope 1 and 2 emissions within operational control and scope 3 emissions that are significant in size or significant from a stakeholder perspective. Towards 2020 their focus is on reporting and reducing emissions from global production sites, company cars, product distribution and business travel.

http://www.novonordisk.com/about-novo-nordisk/novo-nordisk-in-brief/positions/climate-change.html

Global Environmental Management Initiative (GEMI) Tools

Link
7 Jul 2015

A wide range of tools designed by GEMI to help companies improve the environment and provide business value.

Process Mass Intensity Calculation Tool

Link
7 Jul 2015

The PMI Calculator enables you to quickly determine the PMI value by accounting for the raw material inputs and bulk API outputs of a process.

Updated Version - http://www.acs.org/content/dam/acsorg/greenchemistry/industriainnovation/roundtable/Convergent-PMI-Tool.xlsx

Process Mass Intensity Calculator Presentation

Link
7 Jul 2015

The PMI Calculator enables you to quickly determine the PMI value by accounting for the raw material inputs and bulk API outputs of a process.

Updated Version - http://www.acs.org/content/dam/acsorg/greenchemistry/industriainnovation/roundtable/Convergent-PMI-Presentation.pptx

Solvent Selection Guide

Link
7 Jul 2015

The ACS GCI Pharmaceutical Roundtable Solvent Selection Guide .

Update: Another selection guide (2015) has been published as a scientific paper. http://pubs.rsc.org/en/content/articlepdf/2016/gc/c5gc01008j

Antitrust Policy

Organisational Information
6 Jul 2015

The PSCI operates in compliance with the antitrust and competition laws of all applicable countries, including the United States (both state and federal) and European Union. To that end, PSCI has drafted these competition guidelines to serve as a general code of conduct for PSCI as well as its constituent members.

Shared Audit Process Diagram

Document
6 Jul 2015

Through the application of the PSCI Principles, better social, economic and environmental outcomes will result for all those involved in the pharmaceutical supply chain. As an industry, we will focus our efforts on positive social and environmental changes, and building supply chain capacity.

Joint Audit Process Diagram

Document
6 Jul 2015

Through the application of the PSCI Principles, better social, economic and environmental outcomes will result for all those involved in the pharmaceutical supply chain. As an industry, we will focus our efforts on positive social and environmental changes, and building supply chain capacity.

1 2 3 4 5 6 all